Name: Vidarabine

How supplied

NDC 61570-367-71

VIRA-A (vidarabine) Ophthalmic Ointment, 3%, is supplied sterile in ophthalmic ointment tubes of 3.5 g. The base is a 60:40 mixture of solid and liquid petrolatum.

Store at room temperature 15°–30°C (59°F–86°F).

Distributed by: Monarch Pharmaceuticals, Inc., Bristol, TN 37620. Manufactured by: Parkedale Pharmaceuticals, Inc., Rochester, MI 48307.


Normally, corticosteroids alone are contraindicated in Herpes simplex virus infections of the eye. If VIRA-A (vidarabine) Ophthalmic Ointment, 3%, is administered concurrently with topical corticosteroid therapy, corticosteroid-induced ocular side effects must be considered.

These include corticosteroid-induced glaucoma or cataract formation and progression of a bacterial or viral infection.

VIRA-A (vidarabine) is not effective against RNA virus or adenoviral ocular infections. It is also not effective against bacterial, fungal, or chlamydial infections of the cornea or nonviral trophic ulcers.

Although viral resistance to VIRA-A (vidarabine) has not been observed, this possibility may exist.

Uses of Vidarabine

Vidarabine is used in the treatment of:

  • Keratitis, Herpetic
  • Keratoconjunctivitis, Infectious

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Vidarabine Brand Names

Vidarabine may be found in some form under the following brand names:

  • Vira-A

Forms of Medication

Vidarabine is available in the following forms:

  • Injectable Solution